Non-Opioid Pain Management
•12 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (12)
| Company | Market Cap | Price |
|---|---|---|
|
VRTX
Vertex Pharmaceuticals Incorporated
JOURNAVX is a non-opioid pain management therapy, aligning with the non-opioid pain management investable theme.
|
$111.94B |
$441.08
+1.25%
|
|
VTRS
Viatris Inc.
Pipeline includes non-opioid pain management options (e.g., fast-acting meloxicam) as growth drivers.
|
$16.91B |
$14.68
+4.75%
|
|
AXSM
Axsome Therapeutics, Inc.
Symbravo's non-opioid analgesic profile supports Non-Opioid Pain Management as a broader category.
|
$9.53B |
$189.08
+2.65%
|
|
ATRC
AtriCure, Inc.
Pain-management devices (cryoSPHERE family, cryoXT) provide non-opioid analgesia, a key product category.
|
$1.48B |
$29.73
+2.94%
|
|
LXRX
Lexicon Pharmaceuticals, Inc.
Pilavapadin is a non-opioid pain management therapy in development for neuropathic pain, constituting a non-opioid analgesic product category.
|
$679.56M |
$1.89
+2.72%
|
|
ANIK
Anika Therapeutics, Inc.
Non-opioid pain management solutions through HA injections address OA pain.
|
$230.74M |
$16.02
+4.09%
|
|
ASRT
Assertio Holdings, Inc.
INDOCIN, SPRIX, and CAMBIA represent non-opioid analgesics, supporting the Non-Opioid Pain Management theme.
|
$115.57M |
$18.02
|
|
GRCE
Grace Therapeutics, Inc.
GTx-101.00 is a non-narcotic topical analgesic in development for PHN, supporting the 'Non-Opioid Pain Management' theme.
|
$60.61M |
$4.29
+4.13%
|
|
SCLX
Scilex Holding Company
Core business focused on non-opioid pain management drugs and a pipeline of non-opioid therapies.
|
$52.34M |
$6.81
+3.34%
|
|
CPIX
Cumberland Pharmaceuticals Inc.
Caldolor is a non-opioid IV analgesic, aligning CPIX with non-opioid pain management products.
|
$48.31M |
$3.25
+5.18%
|
|
MIRA
MIRA Pharmaceuticals, Inc.
The company's pain therapies are non-opioid analgesics, placing them under 'Non-Opioid Pain Management'.
|
$24.22M |
$1.25
-1.97%
|
|
APUS
Apimeds Pharmaceuticals US, Inc
Apitox functions as a non-opioid analgesic for pain management, aligning with the Non-Opioid Pain Management investable theme.
|
$23.64M |
$1.70
-9.57%
|
Loading company comparison...
Loading industry trends...
Loading research report...
